Pharmaceutical and biopharma manufacturers need to move fluids from one cleanroom to another quickly, with maximum productivity and minimal effort and expense.
Effective viral clearance is at hand with the new, biodegradable J.T.Baker® Viral Inactivation Solution. A sustainable alternative to Triton X-100, this cGMP-ready solution supports...
Have you heard? Experts at Mesa Labs wrote the biological indicator chapter in Handbook of Validation in Pharmaceutical Processes, Fourth Edition. Read the second part of their...
While regulatory compliance is a complex and cumbersome requirement for pharma manufacturers, it is key to ensuring patients receive quality products. Today's ever-increasing ...
Hot off the press! Read the last segment of the biological indicators chapter in Handbook of Validation in Pharmaceutical Processes, Fourth Edition by the experts at Mesa Labs...
Biological indicator professionals at Mesa Labs contributed to the Handbook of Validation in Pharmaceutical Processes, Fourth Edition. Read the first part of their chapter "Biological...
During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...
At Rite-Hite, we have many solutions for the pharmaceutical industry along with the knowledge and experience to help you address the issues you face with your clean areas. We ...
A Contract Manufacturing Organization that produces and packages pharmaceuticals for customers which are then distributed in more than 150 countries found a solution to supply...
New, complex therapies coming through the pharma pipelines are putting immense pressure on supply chains and manufacturing capacity, challenging traditional scale-up and manufacturing...
As more pharma companies look to lower costs, streamline operations, and expand geographical presence, contract manufacturers are increasingly becoming the unsung heroes of pharma...
Outsourcing to contract manufacturers can be a valuable, even critical, option allowing companies to focus their resources and talents on their primary objectives
Drug manufacturers and contract organizations have shared a mutually beneficial relationship for decades in the pharmaceutical industry and will no doubt continue to do so for...
Contract service companies are emerging as the industry's prime movers, tasked with providing the industry with a growing list of increasingly complex services, from early stage...
The manufacture of a Highly Potent Active Pharmaceutical Ingredient (HPAPI) compound can present many challenges due to the complex handling required for toxic substances.
Whether you face challenges like siloed data across multiple departments or addressing specific data security issues or simply feel restricted by the business applications you...
mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...
High concentration mAbs can create challenges for subcutaneous injection, namely pain at the injection site. This peer-reviewed article compares buffer formulation options, and...
Over 70% of potential research participants live >2 hours away from sites, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: eConsent Why...
Cell culture processes are complex and highly variable, and yet only a handful of key parameters are typically controlled in real time. Critical process parameters and key performance...
Nine out of 10 Fortune 500 executives surveyed expressed interest in the idea of outsourcing energy operations to reduce risk. Learn how an Energy as a Service model can support...
The pharma industry is feeling pressure to deliver products at warp speed, leaving companies scrambling to increase productivity without sacrificing quality or breaking the budget...
The pharmaceutical industry is under intense pressure to reduce the environmental harm caused by drug development and manufacturing. Learn about Green Chemistry principles and...
Now more than ever, it is important to protect employees, contractors, and anyone else who accesses your facility's roof. Making rooftop safety a priority at your location can...
With utility costs on the rise, many pharma manufacturers are taking a closer look at their facilities and finding that better facility design, resource management and maintenance...
With many pharma manufacturers operating sophisticated (and costly) continuous water purification systems, results that come days after a sample has been taken do little to ensue...
Often taken for granted until something goes wrong, facility design, resource management and maintenance strategies can offer sources of overlooked savings.
The industry’s most established dosage forms, solid dose drugs are shelf stable and easy to administer. But today's drug formulations are complex and high potency, and OSD drugmakers...
Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.
Dragos's annual ICS/OT Cybersecurity Year in Review provides an overview and analysis of ICS vulnerabilities, global threat activity targeting industrial environments & industry...
The power of simulation in designing a pharmaceutical manufacturing process is due to the unique and detailed information it can provide for many operations. Learn more in this...
Dragos's annual ICS/OT Cybersecurity Year in Review provides an overview and analysis of ICS vulnerabilities, global threat activity targeting industrial environments, and industry...
There are many factors that can affect medication access and initiation. With the power of AI and predictive analytics, patient support interventions can be optimized to allow...
The traditional model for the pharmaceutical industry has focused on the development of blockbuster, broad-spectrum medicines that treat millions of patients globally. However...
Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed...
In biopharmaceutical development, scale up and scale down are critical to developing a robust process and maintaining product quality. This eBook is a resource for best practices...
Packaging plays many roles in today's pharma industry. Not only does the right packaging protect drug quality, it can further sustainability initiatives and even create a strategic...
Pharmaceutical packaging products are getting cleaner, safer, and smarter than ever, and deciding how to choose a supplier requires more thought. Leading producers are laser focused...
Packaging format, materials and innovation have become an interesting discussion of critical importance to the pharmaceutical and biopharmaceutical industry.
Imagine the total number of pharmaceuticals being packaged every day, readied for patient consumption around the world – perhaps too many to count accurately. That is where machine...
Supply chain challenges have always been a fact of life for pharma manufacturers. The pandemic further highlighted the importance of visibility and control across the pharma supply...
What if you could achieve faster off-gas composition analysis without sacrificing precision and quality? Learn how to gain improved precision, accuracy, long intervals between...
Are you working with a pharmaceutical product that requires deep cold storage? Studies have shown that deep cold storage temperatures can introduce risk to the container closure...
Biotechnology and pharmaceutical industries continue to experience increased pressure on financial performance due to several factors, including a rise in the cost of raw materials...
As the industry invests in serialization capabilities to ensure regulatory compliance, they have the opportunity to explore how serialization can be used to develop new processes...
Bringing the Pharma industry closer to it's CAPA goals requires a systematic approach. This special report presents the results and analysis of a recent industry survey indicating...
Supply chain collaboration is underleveraged in the pharmaceutical industry. Other sectors have put more focus on managing their supply chain, but most of pharma’s collaboration...
Oral solid dose formulations — the pharma industry’s tried-and-true treatment forms — continue to play a pivotal role in the industry’s quest to produce quality, effective treatments...
With more than a century of safe, effective usage, oral solid dose products are a proven pharmaceutical market mainstay. While the dosage form isn’t fading away any time soon,...
While the oral solid dosage form has not seen what OSD subject matter expert Dave DiProspero calls a “silver bullet change,” the sector has continued to stay relevant.
Pharmaceutical manufacturers are looking to advance the efficiency and quality of manufacturing solid dose products that are often increasingly complex.
In this paper, Rudolf Schick, director of Spray Analysis and Research Services for Spraying Systems Co., discusses the "why" and "how" of optimizing pharmaceutical spray coating...
Over the last several years, pharmaceutical leaders have come to realize that their old ways of supply chain management are vastly inadequate for today’s hard-hitting challenges...
A start-to-finish guide for understanding and evaluating equipment move options.Organizations need to find the move system that will keep their operations moving swiftly, efficiently...
This year in particular, the pressure has been on pharma to keep pace with the ongoing demand for pandemic products, while also meeting the needs of rapidly expanding areas of...
Pack your bags and join the editors of Pharma Manufacturing as we examine the state of pharma beyond the borders of the United States, exploring the pluses and minus of different...
Pivoting is nothing new for equipment and technology vendors. Innovation is about staying relevant; the most innovative vendors are often those who best adapt to meet the changing...